Journal ArticleOPEN ACCESS

Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway

Cancers (2021) 13(21)
DOI: 10.3390/cancers13215479
30Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

STAT3 is an oncogenic transcription factor that controls the expression of genes associated with oncogenesis and malignant progression. Persistent activation of STAT3 is observed in human.

Author supplied keywords

Cite

CITATION STYLE

APA

Arora, L., Mohan, C. D., Yang, M. H., Rangappa, S., Deivasigamani, A., Kumar, A. P., … Ahn, K. S. (2021). Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway. Cancers, 13(21). https://doi.org/10.3390/cancers13215479

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free